Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients [Phase 2]
Phase 2 neoadjuvant trial in melanoma evaluating Tavo with electroporation in combination with nivolumab (Opdivo); results have been posted …
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer [Phase 1]
Phase I trial of biologics plus chemoradiation therapy for advanced head and neck cancer has completed its Phase I portion.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab [Phase 1]
This is a Phase 1/Ib study of NIZ985 alone and in combination with spartalizumab, sponsored by Novartis, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin
This terminated clinical trial studied nausea and vomiting in patients receiving consecutive days of cisplatin for metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Mentored Community Gardening for Individuals With Skin Cancer [NA]
The University of Arizona study Mentored Community Gardening for Individuals With Skin Cancer has completed, evaluating a gardening-based in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
A terminated Mayo Clinic trial investigated associations between chemotherapy-induced nausea in genitourinary, sarcoma, and melanoma cancers…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors [Phase 1]
Phase 1 study of TBio-6517 alone or in combination with pembrolizumab in solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluates IT-hu14.18-IL2 with radiation, nivolumab and ipilimumab for melanoma; the study is sponsored by the Uni…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Effects of Ultraviolet B Exposure Using a Ultraviolet Skin Care Device on Vitamin D Production and Immune Response in Healthy Adults [NA]
This completed clinical trial evaluated the effects of ultraviolet B exposure from a UV skin care device on vitamin D production and immune …
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma [Phase 1]
Phase Ib LXH254-centric combination study in non-small cell lung cancer and melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) [Phase 3]
Phase 3 study comparing adjuvant pembrolizumab plus vibostolimab (MK-7684A) versus pembrolizumab alone in patients with resected high-risk m…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma [Phase 1]
A Phase 1 study evaluating the safety and activity of BioNTech's investigational cell therapy NEO-PTC-01 in patients with unresectable or me…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Head and Neck Melanoma; Access to Staging and Surgical Treatment
A completed clinical trial from Hull University Teaching Hospitals NHS Trust studied access to staging and surgical treatment for head and n…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating Alomfilimab (KY1044) alone and with atezolizumab in multiple advanced cancers. The trial was terminate…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma [Phase 2]
Phase 2 trial of CMP-001 in combination with nivolumab in advanced melanoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic) [Phase 1]
A Phase 1 clinical trial evaluating fecal microbiota transplantation in combination with immunotherapy for melanoma; the study is currently …
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint Inhibitor Therapy [Phase 1]
Phase 1 trial evaluating XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) for metastatic or advanced melanoma in patients previously tre…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors [Phase 2]
Phase 2 study evaluating the efficacy of tislelizumab and spartalizumab across multiple cancers with PD-1 high mRNA expression; the trial is…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers [Phase 1]
Phase 1 study of the oral STAT3 inhibitor TTI-101 in patients with advanced cancers has completed, with enrollment across multiple tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC) [Phase 1, Phase 2]
A Phase 1b/2 dose-escalation trial of entinostat with pembrolizumab in non-small cell lung cancer, with expansion cohorts in melanoma and co…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma [Phase 1]
Phase 1 study of Nous-PEV for melanoma and non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating SL-279252, a PD-1-Fc-OX40L fusion protein, in adults with advanced solid tumors or lymphomas has been completed wit…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination or sequencing of vemurafenib, cobimetinib, and atezolizumab in patients with high-ris…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study of INCB086550 in Select Solid Tumors [Phase 2]
A Phase 2 trial evaluating INCB086550 across select solid tumors, including non-small cell lung cancer and urothelial carcinoma, was termina…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease [Phase 2]
A Phase 2 trial evaluating the neo-adjuvant combination of talimogene laherparepvec (T-VEC) and nivolumab for resectable stage III/IV melano…